250 related articles for article (PubMed ID: 23378459)
1. Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus.
Akhter E; Shums Z; Norman GL; Binder W; Fang H; Petri M
J Rheumatol; 2013 Mar; 40(3):282-6. PubMed ID: 23378459
[TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
3. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
6. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
[TBL] [Abstract][Full Text] [Related]
7. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study.
Bizzaro N; Ghirardello A; Zampieri S; Iaccarino L; Tozzoli R; Ruffatti A; Villalta D; Tonutti E; Doria A
J Thromb Haemost; 2007 Jun; 5(6):1158-64. PubMed ID: 17388963
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
9. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
12. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
13. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.
Tsutsumi A; Hayashi T; Chino Y; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
Mod Rheumatol; 2006; 16(3):158-64. PubMed ID: 16767554
[TBL] [Abstract][Full Text] [Related]
14. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
[TBL] [Abstract][Full Text] [Related]
15. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
[TBL] [Abstract][Full Text] [Related]
16. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
20. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
Nojima J; Kuratsune H; Suehisa E; Kitani T; Iwatani Y; Kanakura Y
Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
